The Novo Nordisk Pioneer Real Diabetes Trial closes in NHSCT after smashing their recruitment target
December 6, 2022
Pioneer Real A multi-centre, prospective, non-interventional single-arm study investigating clinical parameters associated with the use of once daily oral semaglutide in a real-world adult population with type 2 diabetes closed recently recruiting 381 patients across the UK.
NHSCT had a target recruitment of 8 and surpassed this by recruiting 24 patients, a fantastic achievement by the study team led by Moyra McMaster, Diabetes research nurse.
This made AAH the joint highest recruiter for the study in the entire UK.
To find out more about Novo Nordisk cohort of Pioneer Real Trial click here.